The National Cancer Institute (NCI) is offering a grant opportunity for advanced development and validation of emerging molecular analysis technologies in cancer research. This funding aims to accelerate progress in cancer biology, treatment, diagnosis, early detection, and screening. The grant seeks projects with established proof-of-principle and supportive preliminary data, focusing on technology with a significant impact on cancer research. Proposals using established technologies for novel biological or clinical questions are not eligible. This opportunity is part of NCI’s Innovative Molecular Analysis Technologies (IMAT) Program. Closing date for submissions is September 22, 2015.
Opportunity ID: 271185
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CA-15-003 |
Funding Opportunity Title: | Advanced Development and Validation of Emerging Molecular Analysis Technologies for Cancer Research (R33) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | 10 |
Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jan 08, 2015 |
Last Updated Date: | – |
Original Closing Date for Applications: | Sep 22, 2015 |
Current Closing Date for Applications: | Sep 22, 2015 |
Archive Date: | Oct 23, 2015 |
Estimated Total Program Funding: | $4,000,000 |
Award Ceiling: | $300,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Independent school districts Public and State controlled institutions of higher education Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Special district governments State governments City or township governments Native American tribal governments (Federally recognized) Private institutions of higher education For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This Funding Opportunity Announcement (FOA) solicits grant applications proposing research projects on the advanced development of emerging molecular and cellular analysis technologies and validation in an appropriate cancer-relevant biological system. An emerging technology is defined as one that has passed the pilot developmental stage and shows promise, but has not yet been significantly evaluated within the context of its intended use. If successful, these technologies would accelerate research in cancer biology, cancer treatment and diagnosis, early detection and screening, cancer control and epidemiology, and/or cancer health disparities. This FOA solicits R33 applications where proof-of-principle of the proposed technology or methodology has been established and supportive preliminary data are available. Projects proposed to this FOA should reflect the potential to produce a molecular analysis technology with a major impact in cancer-relevant research. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this FOA and will not be reviewed.
This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-003.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-C | FORMS-C | PKG00211472 | Feb 17, 2015 | Sep 22, 2015 | View |
Package 1
Mandatory forms
271185 RR_SF424_2_0-2.0.pdf
271185 PHS398_ResearchPlan_2_0-2.0.pdf
271185 PHS398_CoverPageSupplement_2_0-2.0.pdf
271185 RR_Budget_1_3-1.3.pdf
271185 RR_KeyPersonExpanded_2_0-2.0.pdf
271185 RR_OtherProjectInfo_1_3-1.3.pdf
271185 PerformanceSite_2_0-2.0.pdf
Optional forms
271185 PlannedReport-1.0.pdf
271185 PHS398_CumulativeInclusionReport-1.0.pdf
271185 RR_SubawardBudget30_1_3-1.3.pdf